迪瑞醫療檢驗產品已出口到 100 多個國家和地區，醫療檢驗產品在行業精棄求內率先通過了歐盟的CE認證和美國的 FDA 認證，迪瑞質量管理體系通過了ISO9001 ISO13485國際質量體系認證。
迪瑞奉行：探紋喇立足醫學檢驗領域，科學創新、嚴謹安全、誠實守信的理念，為客戶提供優質的產品和服務。
迪瑞擁有高素質的研發團隊，自主研發的檢驗分析產品擁有多項碑想試設計專利。
研發成果
1992年，研製出品格背協乃8項尿液分析試紙
1995年，研製出品10項尿液分析試紙
1997年，研製出品11項尿分析試紙
1998年，研製出品抗VC尿液分析試紙
1999年，研製出品H-100型尿液分析儀和配套系列試紙
2001年，研製出品尿液分析質控液。
2001年，研製出品H-500型、H-300型、H-50型尿液分析儀
2004年，研製出品H-800型全自動尿液分析儀
2005年，研製出品多項生化試劑
2005年，研製出品半自動生化分析儀
2007年，研製出品全自動血球計數儀
2007年，研製出品全自動生化分析儀（240、400個測試）
2008年，研製出品全自動生化分析儀（600、800個測試）
2008年，研製出品全自動五分類血球計數儀和全自動尿有形成分分析儀（流式圖像法）
2009年，研製出品生化免疫試劑
2009年，研製出品全自動生化分析儀（模組化3200個測試）
2009年，研製出品桌式全自動生化分析儀
2010年，研製出FUS-200全自動尿有形成分分析儀
2010年，研製出BF系列全自動五分類細胞分析儀
2010年，研製出全自動生化分析儀（1600個測試和模組化6400個測試）
2011年，研製出品FB-100全自動便潛血分析儀
Dirui is becoming a leading international medical products supplier.
Dirui is located in the New & High tech Development zone of Changchun, China. It is a high technology enterprise granted by Science Ministry of P.R. China. It is also an undertaker to National Torch Plan Project and a supporter of National Innovation Fund. Dirui owns two subsidiaries - Dirui Industrial and Dirui Pharmaceutical Co., Ltd. with their targeted market in medical devices, diagnostic reagents and pharmaceuticals respectively.
Since established in 1992, Dirui has been following a market-oriented strategy and maintaining its business philosophy as "meeting customers' needs". The company has concentrated on developing, producing and selling high quality medical and pharmaceutical products which now have been divided into three main categories of pharmaceuticals, diagnostic reagents and chemical analyzers. Our pharmaceuticals include such as tablets, capsule, mixture, oral solution, injection solution etc. with totally 154 kinds of listed products. So far, we have got many national invention patents. Dirui is the first Chinese manufacturer who owns anti-VC technology for reagent strips, its technical index has reached international advanced level; and Dirui's control for urinalysis is the first liquid control in China. Furthermore, the series urine analyzers adopting 6 wavelength optical technique are superior than other similar products because of their more stable and reliable performance.
Up to now, Dirui's products have been exported to more than 60 countries and regions. They primarily got ISO9001, ISO13485,CE Mark, and FDA approval.
We pursue precise science, keep the faith of honesty, and believe in the management concept of solidarity and innovation. On the basis of customer needs, we have built an integrated management and service system which aims at providing superior products and service for our customers.
上市IPO
2012年4月25日，公司上市通過證監會發行審核委員會審核，正式發布發招股說明書，登入創業板。.
長春迪瑞醫療科技基本資料
基本狀況
公司名稱
長春迪瑞醫療科技
發行前總股本
4600.00 萬股
擬發行後總股本
6134.00 萬股
擬發行數量
1534.00 萬股
占發行後總股本
25.01 %
相關公告
長春迪瑞醫療科技股份有限公司創業板首發招股說明書（申報稿）
重要財務指標(截至2011年12月31日)
每股收益
1.66
發行前每股淨資產
5.47 元/股
每股現金流量
0.85
淨資產收益率
35.75 %
承銷商與利潤分配
主承銷商
國信證券股份有限公司
承銷方式
餘額包銷
發審委委員
王秀萍 王國海 任鵬 李童雲 陳靜茹 康吉言 譚紅旭
利潤分配
本次發行完成前滾存的未分配利潤由本次發行後的新老股東按發行後的持股比例共同享有。
主營業務
尿液、尿沉渣、生化、血細胞等醫療檢驗儀器以及配套試紙試劑（含校準品、質控液等）的研發、生產與銷售。
募集資金將用於的項目
序號
項目名稱
投資額（萬元）
1
年產6，000台全自動臨床檢驗設備及90，000盒配套試劑規模化生產項目
24000
2
研發工程中心建設項目
13000
3
行銷網路中心建設項目
5000
合 計
42000
長春迪瑞醫療科技——最近三年財務指標
財務指標/時間
2011年
2010年
2009年
總資產（億元）
3.859
2.324
1.701
淨資產（億元）
2.516
1.753
0.974
少數股東權益（億元）
0.0425
營業收入（億元）
3.5806
2.3119
1.7565
淨利潤（億元）
0.7631
0.6023
0.1891
資本公積（億元）
0.9792
0.9792
0.0146
未分配利潤（億元）
0.9694
0.2824
0.5237
基本每股收益（元）
1.66
1.38
0.62
稀釋每股收益（元）
1.66
1.38
0.62
每股現金流（元）
0.85
0.3
0.13
淨資產收益率（%）
35.75
49.27
22.31
長春迪瑞醫療科技主要股東
序號
股東名稱
持股數量
占總股本比例
1
瑞發投資
33,000,000
71.74
2
宋 勇
5,308,600
11.54
3
復星醫藥
2,970,000
6.46
4
宋 潔
2,413,000
5.25
5
顧小豐
1,930,400
4.20
6
張力沖
50,000
0.11
7
於明新
50,000
0.11
8
仲維宇
50,000
0.11
9
余同樂
30,000
0.07
10
汪 博
25,000
0.05
經營內容
IVD檢測儀器及配套耗材
Dirui is becoming a leading international medical products supplier.
Dirui is located in the New & High tech Development zone of Changchun, China. It is a high technology enterprise granted by Science Ministry of P.R. China. It is also an undertaker to National Torch Plan Project and a supporter of National Innovation Fund. Dirui owns two subsidiaries - Dirui Industrial and Dirui Pharmaceutical Co., Ltd. with their targeted market in medical devices, diagnostic reagents and pharmaceuticals respectively.
Since established in 1992, Dirui has been following a market-oriented strategy and maintaining its business philosophy as "meeting customers' needs". The company has concentrated on developing, producing and selling high quality medical and pharmaceutical products which now have been divided into three main categories of pharmaceuticals, diagnostic reagents and chemical analyzers. Our pharmaceuticals include such as tablets, capsule, mixture, oral solution, injection solution etc. with totally 154 kinds of listed products. So far, we have got many national invention patents. Dirui is the first Chinese manufacturer who owns anti-VC technology for reagent strips, its technical index has reached international advanced level; and Dirui's control for urinalysis is the first liquid control in China. Furthermore, the series urine analyzers adopting 6 wavelength optical technique are superior than other similar products because of their more stable and reliable performance.
Up to now, Dirui's products have been exported to more than 60 countries and regions. They primarily got ISO9001, ISO13485,CE Mark, and FDA approval.
We pursue precise science, keep the faith of honesty, and believe in the management concept of solidarity and innovation. On the basis of customer needs, we have built an integrated management and service system which aims at providing superior products and service for our customers.
